Wellgistics Health, Inc. announced its financial results for the second fiscal quarter ended June 30, 2025, on August 20, 2025. For the first half of 2025, net revenues reached $18.65 million. This compares to $44,540 in the comparable period of 2024, reflecting substantial growth.
The company reported a gross profit of $1.20 million for the six-month period, with a gross margin of 6.4%. However, Wellgistics Health reported a net loss of $39.10 million for H1 2025. This compares to a net loss of $657,447 for the same period in 2024.
General and administrative expenses for H1 2025 were $36.03 million, largely driven by $28.31 million in non-cash stock-based compensation. Net cash used in operating activities was $3.43 million for the six months ended June 30, 2025. The company's accumulated deficit reached $48.86 million as of June 30, 2025.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.